Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
In this study, typical cases of coronary heart disease are selected. They will be intervened by Xuesaitong soft capsules to investigate efficacy and safety for Coronary Heart disease.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Xuesaitong soft capsule group | Experimental | Patients who confirmed by coronary angiography and diagnosed blood stasis syndrome of coronary heart disease are given conventional Western medicine treatment and Xuesaitong soft capsule. |
|
| Placebo Comparator | Placebo Comparator | Patients who confirmed by coronary angiography and diagnosed blood stasis syndrome of coronary heart disease are given conventional Western medicine treatment and placebo. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Xuesaitong soft capsule | Drug | Panax Notoginseng Saponins, Specification:0.33 per bag, once take two pills and twice a day during a month. |
|
| Measure | Description | Time Frame |
|---|---|---|
| major adverse cardiovascular events | death, myocardial infarction, hospitalization for unstable angina or stroke | 60 days |
| Seattle Angina Questionnaire | to evaluate patients by Seattle Angina Questionnaire | 60 days |
| blood stasis syndrome scale of Coronary heart disease angina pectoris | to evaluate patients by blood stasis syndrome scale of Coronary heart disease angina pectoris | 60 |
| Measure | Description | Time Frame |
|---|---|---|
| lipid | Triacylglyceride,total cholesterol, low densith lipoprotein, high densith lipoprotein | 60 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Lian Duan | Contact | +8601088001817 | popale2003@163.com |
| Name | Affiliation | Role |
|---|---|---|
| Jie Wang | Guang Anmen Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Guang Anmen Hospital | Recruiting | Beijing | Beijing Municipality | 100029 | China |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 35784716 | Derived | Duan L, Liu Y, Li J, Zhang Y, Dong Y, Liu C, Wang J. Panax notoginseng Saponins Alleviate Coronary Artery Disease Through Hypermethylation of the miR-194-MAPK Pathway. Front Pharmacol. 2022 Jun 16;13:829416. doi: 10.3389/fphar.2022.829416. eCollection 2022. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003327 | Coronary Disease |
| D000789 | Angina, Unstable |
| ID | Term |
|---|---|
| D017202 | Myocardial Ischemia |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D014652 | Vascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Placebo oral capsule | Drug | Xuesaitong soft capsule Placebo, soft capsule, once take two pills and twice a day during a month. |
|
| D000787 |
| Angina Pectoris |
| D002637 | Chest Pain |
| D010146 | Pain |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |